Kura Oncology, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 4.51M | $36.68M | 0.00% | Trimmed-8.5% | 2026-03-31 |
| RenTech | quant | 1.58M | $12.87M | 0.02% | Trimmed-13.5% | 2026-03-31 |
| TwoSigma | quant | 358.0K | $2.91M | 0.00% | Trimmed-24.1% | 2026-03-31 |
| FidelityFMR | fundamental | 317.7K | $2.58M | 0.00% | Added+3.6% | 2026-03-31 |
| TRowePrice | fundamental | 58.1K | $473 | 0.00% | Added+27.0% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-06upcoming | -0.91 | — | — |
| 2026-03-05 | -0.74 | -0.92 | -24.12% |
| 2025-11-04 | -0.68 | -0.85 | -25.78% |
| 2025-08-07 | -0.37 | -0.75 | -102.82% |
| 2025-05-01 | -0.32 | -0.66 | -108.02% |
| 2025-02-26 | -0.64 | -0.22 | +65.49% |
| 2024-11-07 | -0.61 | -0.63 | -2.96% |
| 2024-08-08 | -0.62 | -0.59 | +4.58% |
| 2024-05-02 | -0.54 | -0.59 | -9.81% |
| 2024-02-27 | -0.54 | -0.55 | -1.05% |
| 2023-11-02 | -0.55 | -0.50 | +9.63% |
| 2023-08-03 | -0.56 | -0.53 | +4.79% |
| 2023-05-10 | -0.54 | -0.50 | +7.79% |
| 2023-02-23 | -0.57 | -0.49 | +14.53% |
| 2022-11-03 | -0.56 | -0.53 | +5.78% |
| 2022-08-03 | -0.52 | -0.52 | +0.27% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| KURA | +16.31% | +20.00% | -1.83% | +79.26% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +13.34% | +24.64% | +1.61% | +66.57% |